Evidence, Access & Pricing
Value
We support our clients to develop and communicate a clear value strategy that is supported by compelling evidence.
Evidence, Access & Pricing
We support our clients to develop and communicate a clear value strategy that is supported by compelling evidence.
Providing the right evidence to payers and other key access stakeholders is essential to unlock the pricing and access potential of therapies (new and on-market). Working across the product lifecycle, and by leveraging our deep and long-standing experience with payers and other stakeholders, Trinity experts can help clients to:
Our experts have a deep understanding of the payer audience and how to impactfully communicate the key points of a value proposition in a compelling way that is targeted and refined to audience.
The Trinity Difference:
The U.S. health economics and outcomes research (HEOR) field has seen many changes over the last decade, including significant growth driven by payers, regulators and clinicians who are increasingly looking to Real-World Evidence (RWE) as a valuable source for patient-level data. […]
This session will discuss trends in the HTA/Reimbursement environment in Latin America and the drivers for value-based health care (VBHC) implementation within the region. The potential benefits of VBHC […]
French president Emmanuel Macron announced a two-year trial that will allow pharmaceutical products that receive an ‘Amélioration du Service Médical Rendu’ (ASMR) rating of IV or better to get reimbursement […]
Up to nine biosimilar versions of Humira (adalimumab) are expected to launch in 2023 in the United States, following settlements between AbbVie and their respective manufacturers. In contrast, biosimilar versions of adalimumab have been available in most countries […]
Senior Partner &
Head of Advisory and Evidence, Value, Access and Pricing (EVAP)
Monica’s career has focused on pharmaceutical global pricing and market access issues for biopharmaceutical and pharmaceutical products. Her time has been apportioned between the mature and emerging markets, with deep expertise in the U.S., EU5, CAN and JPN. Monica has worked across the major therapeutic areas (oncology, cardiovascular, neurology, metabolic, autoimmune, gastrointestinal, respiratory, etc.) collaborating […]
Managing Director
Rob is a Managing Director in Trinity’s Evidence, Value, Access and Pricing practice. Prior to joining Trinity, Rob was a Managing Director (Partner) at L.E.K. Consulting. Rob has 20+ years of healthcare strategy consulting experience, including ~15 years of Market Access and commercial strategy experience. His Market Access experience includes developing launch, pricing, innovative and […]
Director,
Value, Access & Pricing
Ms. Boers is a Director in Trinity’s Value, Access & Pricing practice. Prior to joining Trinity, Ms. Boers was part of the CBPartners team and focused her experience on pricing and market access engagements, proving strategic support to optimize value communication, product positioning, IRP-based launch sequence and pricing opportunity across a range of therapeutic areas, […]
Partner,
Value, Access & Pricing
Christian is a recognized and widely published expert on pricing, contracting, market access and payer evidence strategy. He leads Trinity’s pricing, market access, reimbursement and contracting (PARC) group, and has supported the development of PARC strategies for more than 50 assets in the US and ex-US.
Partner,
Value, Access & Pricing
Andrew is a Partner in Trinity’s Value, Access and Pricing practice and has over 15 years working within the Life Sciences arena. Prior to joining Trinity, he led CBPartners’ U.S. Center of Excellence and focused on managed markets strategy engagements. His experience has emphasized the development of numerous pricing and access strategies for both pre-launch […]
Partner,
Value, Access & Pricing
John has 25 years of consulting experience and is currently a leadership team member within Trinity’s Evidence, Value, Access and Pricing (EVAP) practice. John is an expert in U.S. Reimbursement and Contracting where he focuses on Market Access Strategy through Managed Care and Provider / GPO Contract Strategies and sustainable contract structure and design. In […]
Partner,
Evidence Strategy
An economist by training, Nandini is a Partner at Trinity Life Sciences with over two decades of experience in custom research and strategy consulting. She is an expert at helping clients identify what real-world evidence will “move the needle” and drive their product’s success, generating that evidence using publication-grade research, and pulling the insights through […]
Partner,
Value, Access & Pricing
Max is a Partner in Trinity’s Value, Access and Pricing practice. His experience as a global life sciences strategy consultant spans all stages of product development and a wide range of therapeutic areas, including oncology, inflammatory conditions, rare diseases and cell and gene therapies. Prior to joining Trinity, Max’s engagement work at CBPartners targeted a […]
Partner,
Value, Access & Pricing
Prior to joining Trinity, Mr. Martín de Bustamante worked across CBPartners’s practices, with a focus on Value, Access, and Pricing. He developed expertise across many related areas, including innovative contracting and access models, strategic product / portfolio positioning, IRP and commercial opportunity based launch sequencing, as well as value positioning across various therapeutic areas. He […]
Partner,
Evidence Strategy
Matt joins Trinity with over 20 years of life sciences consulting experience. During his career, Matt has worked with both pharmaceutical and medical device clients across business/commercial strategy (pricing, market access, product portfolio rationalization, acquisitions, Intellectual Property, and market insights), HEOR (value proposition development, evidence generation planning, and literature reviews, budget impact and comparative effectiveness […]
Partner, Value, Access & Pricing
& London Office Lead
Prior to joining Trinity, Ms. Oshinowo led engagement work within the Value, Access and Pricing Practice and drove the Early VAP & CP Centre of Excellence at CBPartners. Her primary expertise is on early-stage pipeline issues related to commercial strategy, including competitive positioning, pricing, market access and trial design optimization. Her geographical expertise includes the USA […]
Director,
Evidence, Value, Access & Pricing
Mr. Park is a Director in Trinity’s Value, Access & Pricing practice. Prior to joining Trinity, Mr. Park’s work at CBPartners was primarily focused on pricing, market access, and value demonstration engagements in support of strategic planning with a variety of biopharmaceutical clients. Mr. Park has led many global (including USA, EU, APAC and LatAm) […]
Principal,
Value, Access & Pricing
Julia is a Principal in Trinity’s Value, Access & Pricing practice. Prior to joining Trinity, Julia led engagement work within the Value, Access and Pricing Practice and drove the Cell and Gene Therapy Centre of Excellence at CBPartners. In this capacity, she supported a range of qualitative and quantitative engagements to inform current and future […]
Managing Director
Greg is a Managing Director in Trinity’s Evidence, Value, Access and Pricing practice, leading the Access Analytics team. Prior to joining Trinity, Greg was a Senior Vice President at Precision, Value and Health. Greg has 30+ years of healthcare consulting and industry experience, including ~20 years of market access and commercial strategy experience. He has […]
Managing Director
Mary brings over 25 years of healthcare and consulting experience to Trinity. As a VP at DRG, Mary played leadership roles in various domains including global market access, HEOR, market forecasting and primary market research. For several years, Mary led DRG’s Value Communication Center of Excellence. Most recently, Mary was Head of Consulting at CREATION.co, […]
If you have any questions, we’re here to answer them.
We look forward to helping identify solutions for you.